Exact Mass: 435.02688320000004
Exact Mass Matches: 435.02688320000004
Found 85 metabolites which its exact mass value is equals to given mass value 435.02688320000004
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cloxacillin
C19H18ClN3O5S (435.06556480000006)
Cloxacillin is only found in individuals that have used or taken this drug. It is a semi-synthetic antibiotic that is a chlorinated derivative of oxacillin. [PubChem]By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, cloxacillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cloxacillin interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CF - Beta-lactamase resistant penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Glucoraphenin
Acquisition and generation of the data is financially supported in part by CREST/JST.
5-Methylthiopentylglucosinolate
5-methylthiopentylglucosinolate is a member of the class of compounds known as alkylglucosinolates. Alkylglucosinolates are organic compounds containing a glucosinolate moiety that carries an alkyl chain. 5-methylthiopentylglucosinolate is slightly soluble (in water) and an extremely strong acidic compound (based on its pKa). 5-methylthiopentylglucosinolate can be found in a number of food items such as kale, garden cress, oxheart cabbage, and coconut, which makes 5-methylthiopentylglucosinolate a potential biomarker for the consumption of these food products.
Aztreonam
Aztreonam is only found in individuals that have used or taken this drug. It is a monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms. [PubChem]The bactericidal action of aztreonam results from the inhibition of bacterial cell wall synthesis due to a high affinity of aztreonam for penicillin binding protein 3 (PBP3). By binding to PBP3, aztreonam inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins. It is possible that aztreonam interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DF - Monobactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
5-Chloro-N-({2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide
C19H18ClN3O5S (435.06556480000006)
1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D063385 - Cannabinoid Receptor Modulators D018377 - Neurotransmitter Agents > D063385 - Cannabinoid Receptor Modulators > D063386 - Cannabinoid Receptor Agonists
Laropiprant
C21H19ClFNO4S (435.0707296000001)
Inhibitor 50
Glucoraphenin
Glucoraphenin is a member of the class of compounds known as alkylglucosinolates. Alkylglucosinolates are organic compounds containing a glucosinolate moiety that carries an alkyl chain. Glucoraphenin is slightly soluble (in water) and an extremely strong acidic compound (based on its pKa). Glucoraphenin can be found in radish, which makes glucoraphenin a potential biomarker for the consumption of this food product.
5-chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide
C19H18ClN3O5S (435.06556480000006)
10beta-(N-trichloroacetyl-carbamate)-13-hydroxy-marasm-7(8)-en-5-oic acid gamma-lactone
C18H20Cl3NO5 (435.0407000000001)
(E)-3-(3,5-dibromo-4-methoxyphenyl)-2-hydroxyimino-N-(3-(methylamino)propyl)propanamide|pseudoceramine D
C14H19Br2N3O3 (434.97930640000004)
8-Acetamido-1,1,15,15,15-pentachloropentadeca-3-yne
2-(4-(4-Chlorobenzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid
C21H19ClFNO4S (435.0707296000001)
aztreonam
A synthetic monocyclic beta-lactam antibiotic (monobactam). J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DF - Monobactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
Laropiprant
C21H19ClFNO4S (435.0707296000001)
C177182 - Prostaglandin Receptor Antagonist C26170 - Protective Agent
9H-Carbazole,3,6-dibromo-9-(2-ethylhexyl)-
C20H23Br2N (435.01971180000004)
2,7-dibromo-9-(2-ethylhexyl)-9H-carbazole
C20H23Br2N (435.01971180000004)
4-Bromo-3-bis(tert-butoxycarbonyl)amino-thiophene-2-carboxylic acid Methyl ester
C16H22BrNO6S (435.03511320000007)
2-(2-Benzothiazolyl)-3,5-diphenyltetrazolium Bromide
C20H14BrN5S (435.01532240000006)
Rivaroxaban
C19H18ClN3O5S (435.06556480000006)
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AF - Direct factor xa inhibitors C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C173067 - Direct Factor Xa Inhibitor C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C180619 - Direct Oral Anticoagulant D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Naphthol AS-TR phosphate disodium salt
C18H13ClNNa2O5P (435.0015248000001)
tris-(Acetonitrile)cyclopentadienyl ruthenium(I)
C11H14F6N3PRu (434.98728860000006)
(R)-5-chloro-N-(4-(3-oxomorpholino)phenyl)-N- ((2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide
C19H18ClN3O5S (435.06556480000006)
VX-745
C19H9Cl2F2N3OS (434.98114280000004)
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor
1-Pyrazolidinecarboxamide, N-(4-bromophenyl)-3-oxo-4,5-diphenyl-, (4S,5R)-
[5-(4-Chlorophenyl)-1-(3,4-dichlorophenyl)-3-pyrazolyl]-(4-morpholinyl)methanone
tert-butyl N-[2-[5-[(2,4-dichlorophenyl)methylsulfonyl]-1,3,4-oxadiazol-2-yl]ethyl]carbamate
C16H19Cl2N3O5S (435.0422424000001)
N-[3-(2-methoxyethyl)-6-methylsulfonyl-1,3-benzothiazol-2-ylidene]-2-nitrobenzamide
Glycine, N-ethyl-N-[(undecafluoropentyl)sulfonyl]-
C9H8F11NO4S (434.99983800000007)
N-[(1s)-2-Amino-1-(2,4-Dichlorobenzyl)ethyl]-5-[2-(Methylamino)pyrimidin-4-Yl]thiophene-2-Carboxamide
C19H19Cl2N5OS (435.06873040000005)
5-Acetyl-4-{[(2,4-dimethylphenyl)sulfonyl]amino}-2,2-bithiophene-5-carboxylic acid
C19H17NO5S3 (435.02688320000004)
4-Hydroxy-5-iodo-3-nitrophenylacetyl-epsilon-aminocaproic acid anion
Glucoberteroin
A thia-alkylglucosinolic acid that consists of 1-thio-beta-D-glucopyranose attached to a 6-(methylsulfanyl)-N-(sulfooxy)hexanimidoyl group at the anomeric sulfur.
3-[[5-[(1-Carboxy-3-oxopropan-2-yl)carbamoyl]pyridin-2-yl]methylsulfamoyl]benzoic acid
[(2S,3R,4S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-6-methylsulfanyl-N-sulfooxyhexanimidothioate
N-(1,3-benzothiazol-2-yl)-3-(2,3-dihydroindol-1-ylsulfonyl)benzamide
C22H17N3O3S2 (435.07112920000003)
2-[4-[[(3,4-Dichlorophenyl)-oxomethyl]amino]phenyl]-3,3,3-trifluoro-2-hydroxypropanoic acid ethyl ester
C18H14Cl2F3NO4 (435.02519400000006)
N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-3-methoxy-2-thiophenesulfonamide
C14H11F6NO4S2 (435.00336780000004)
2-deoxy-4-O-alpha-L-idopyranuronosyl-2-(sulfoamino)-alpha-D-glucopyranose
(R)-4-phospho-S-sulfopantetheine
C11H20N2O10PS2-3 (435.02969700000006)
1-S-[(1Z)-6-(methylsulfanyl)-N-(sulfooxy)hexanimidoyl]-1-thio-beta-D-glucopyranose
(2S,5S,6R)-6-[[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]-oxomethyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
C19H18ClN3O5S (435.06556480000006)
2-amino-2-deoxy-4-O-alpha-L-idopyranuronosyl-6-O-sulfo-alpha-D-glucopyranose
Cloxacillin
C19H18ClN3O5S (435.06556480000006)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CF - Beta-lactamase resistant penicillins A semisynthetic penicillin antibiotic carrying a 3-(2-chlorophenyl)-5-methylisoxazole-4-carboxamido group at position 6. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Azactam
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D063385 - Cannabinoid Receptor Modulators D018377 - Neurotransmitter Agents > D063385 - Cannabinoid Receptor Modulators > D063386 - Cannabinoid Receptor Agonists
[(z)-[6-(methylsulfanyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}hexylidene]amino]oxysulfonic acid
(3ar,4ar,8ar,9ar)-8a-methyl-3,5-dimethylidene-2-oxo-hexahydro-3ah-naphtho[2,3-b]furan-4a-yl n-(2,2,2-trichloro-1-hydroxyethylidene)carbamate
C18H20Cl3NO5 (435.0407000000001)
[(z)-[(4e)-5-[(s)-methanesulfinyl]-1-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino]oxysulfonic acid
[(e)-[6-(methylsulfanyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}hexylidene]amino]oxysulfonic acid
(1s,3r,4s,7r,8s)-3,6,6-trimethyl-13-oxo-12-oxatetracyclo[8.3.0.0¹,³.0⁴,⁸]tridec-9-en-7-yl n-(2,2,2-trichloro-1-hydroxyethylidene)carbamate
C18H20Cl3NO5 (435.0407000000001)
(2s,5r,6r)-6-({[3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl](hydroxy)methylidene}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
C19H18ClN3O5S (435.06556480000006)
n-[(8r)-1,1,15,15,15-pentachloropentadec-3-yn-8-yl]ethanimidic acid
[(z)-[6-(methylsulfanyl)-1-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}hexylidene]amino]oxysulfonic acid
n-(1,1,15,15,15-pentachloropentadec-3-yn-8-yl)ethanimidic acid
n-(1,3,3,4,4-pentachloropentadec-1-yn-5-yl)ethanimidic acid
3,6,6-trimethyl-13-oxo-12-oxatetracyclo[8.3.0.0¹,³.0⁴,⁸]tridec-9-en-7-yl n-(2,2,2-trichloro-1-hydroxyethylidene)carbamate
C18H20Cl3NO5 (435.0407000000001)
(2r,3r,4r,5r,6s,7s)-4-(acetyloxy)-5-amino-2,3,7-trihydroxy-6-(phosphonooxy)thiocane-2,7-dicarboxylic acid
C11H18NO13PS (435.02364680000005)
8a-methyl-3,5-dimethylidene-2-oxo-hexahydro-3ah-naphtho[2,3-b]furan-4a-yl n-(2,2,2-trichloro-1-hydroxyethylidene)carbamate
C18H20Cl3NO5 (435.0407000000001)
{[6-(methylsulfanyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}hexylidene]amino}oxysulfonic acid
[(z)-[(4e)-5-methanesulfinyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino]oxysulfonic acid
4-(acetyloxy)-5-amino-2,3,7-trihydroxy-6-(phosphonooxy)thiocane-2,7-dicarboxylic acid
C11H18NO13PS (435.02364680000005)